PeptideTracker
177 posts

PeptideTracker
@PepCalc
All-in-one peptide tracker and calculator

NEW: Martha Stewart raises $10 million in seed funding for her AI startup.

Reta vs tirz🏆🥈 pros and cons 🥈🏆 Reta🏆 ——————————————————— More overall weight loss 🏴☠️ Burn more calories at baseline 🏴☠️ Can actually eat and get your calories in 🏴☠️ Sleep disturbance seems worse ❌ Larger increase in RHR❌ Not as studied ❌ Tirz🥈 ——————————————————— Stronger overall appetite suppression🏴☠️ Longer track record 🏴☠️ Not as many sleep disturbance or heart rate concerns 🏴☠️ Nausea is more common ❌ Less weight loss overall ❌ Some experience more fatigue on tirz❌ (Based off feedback from old post)📝 🔬🧬


"I think what tech people misunderstand is just the size of the TAM in pharma." @zebulgar says capital will rotate into pharma after AGI: "Anthropic is at what, a $60B run rate? Keytruda, the drug that Merck did in 2019, that one drug's topline is $25B in revenue. Just that one drug." "By the way, once there's AGI, what do you think everybody's going to be focused on afterwards? Everybody's just going to want to live forever. Where do you think the capital is going to rotate into? It's going to rotate into longevity, therapeutics, and manufacturing."

My buddy got out of a 2 year relationship and was genuinely depressed for almost a year. Gained weight, stopped going out, looked awful, kept checking her IG, whole thing cooked him mentally. He started taking Reta like 2 months ago he’s down 20+ lbs, running every morning, skin cleared up, jawline came back, dressing better, and even is going on dates. Says he’s over his ex completely Starting to think Retatrutide might secretly be the breakup recovery drug?



Everyone called $PLTR a consulting company at $7. I said it was an AI platform being born. AIP came. The rest is history. $HIMS just had its Palantir moment. The numbers look ugly. They are supposed to. This is what a transformation looks like before everyone understands what is being built.

The world's top longevity doctors are calling peptides the future of medicine. I spent 100+ hours watching every major peptide interview on the internet to understand exactly what they are and the science behind them. Here are the 8 best, ranked:🧵 8) Dr. Alex Tatem on DOAC


I think I just found a banger

This was printed as a sensible way to lose 5lbs (2,27kg) in 3 days Vogue 1977

The future of Peptides is NOT looking good for $HIMS After a MASSIVE MASSIVE miss on EPS with their earnings today.


2026 is proving to be a defining year at Hims & Hers. More and more, we are the partner people rely on for a simpler, more personal path to feeling great. Our Q1 2026 results are now live and they make it clear that we aren’t just growing. We’re showing the world what happens when you focus on transforming what people believe is possible in healthcare. Here’s what to know from today’s numbers: - We’re building momentum in the US. There are more ways than ever for customers to start – and stay – with Hims & Hers. That’s driving momentum across all of our specialties, especially weight loss, where we’re seeing near-record adoption levels since March. Our strategic shift is paying off. - Our global reach is multiplying our impact. As we expand globally, we’ll bring more data points into our ecosystem and extend the network effects of our platform. This isn’t just good for our customers. It’s good for our partners, too, who are starting to see the potential in a high-touch, personal platform experience designed to help customers stick to their treatment plans longer and achieve their goals better than with medication alone. - We have deeper-than-ever relationships with our customers. We’re moving beyond simply responding to symptoms by investing in areas like diagnostics that make it easier for anyone to feel their best. We’re now a trusted, comprehensive health partner that’s helping customers proactively discover early signs of conditions that may not be symptomatic yet. - Our platform is getting harder to replicate. Our technology and data infrastructure is getting more agile and more intelligent with tens of millions of customer touchpoints. We power the end-to-end customer experience, which means we’re constantly growing a closed-loop, proprietary data flywheel that we believe is unmatched. I’ve never been more confident in the future of health – and I’ve never been more sure that we’re the ones building it. More on this quarter’s results: news.hims.com/newsroom/how-w… Important info here: investors.hims.com/news/news-deta… news.hims.com/disclaimers/di…
